Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
Technology Prolactin Receptor Antibodies For Targeted Cancer Therapy And Diagnosis Novel antibodies precisely targeting cancer cells by binding to the Prolactin Receptor (PRLR) to diagnose cancer, direct immune cells to destroy tumors, and inhibit cancer growth signals, without affecting healthy…
News 3 Novel Disease-Fighting Technologies You Should Know About Ahead of BIO 2022 Researchers at the University of Chicago have developed methods to increase the clinical efficacy of immunotherapies, provide long-lasting immune tolerance for autoimmune or transplantation therapy, and treat breast and ovarian...
News Novel Breast Cancer Therapy Shows Promise Moving a basic scientific finding from a lab to the clinical setting is the Holy Grail for medical researchers the world over. Suzanne Conzen, MD, professor of hematology/oncology at the...
News Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a...
News Duckworth Family’s Partnership Drives Cancer Discoveries to Market A $1 million gift will establish the Duckworth Family Cancer Fund at the University of Chicago Medicine to accelerate the pace of cancer discoveries brought to market.
Technology A Primary 3D Culture Model for the High Throughput Ex-vivo Modeling of Ovarian Cancer Metastasis Current high throughput screens for ovarian cancer drug discovery use monolayer cell culture on plastic, and problematically cannot accurately model the cross communication between the cancer cells and the tumor…
Technology Antibody-Polymer Conjugates For Engaging T Cells To Destroy Cancer Cells An antibody linked to a polymer that connects T cells to cancer cells enabling broad cancer targeting and effective tumor cell killing without needing tumor-specific antigens The Unmet Need: Novel…
News Cancer’s Achilles’ Heel? UChicago Startup Secures $7 Million to Develop ‘Game-Changer’ Treatments Onchilles Pharma recently closed its Series A funding round, bringing in approximately $7 million, including a $500,000 investment from the University of Chicago’s Startup Investment Fund. Cofounded by UChicago Associate...
Technology Boosting Cancer Immunotherapy Or Radio-Immunotherapy For Enhanced Tumor Eradication New cancer therapy to enhance the efficacy of checkpoint inhibitor immunotherapy and radiation by blocking tumor-promoting signals from erythroid progenitor cells, which secrete artemin to advance cancer progression. This approach…
News OrisDX Wins 2022 Edward L. Kaplan, ’71, New Venture Challenge with Saliva Test to Diagnose Oral Cancers UPDATE: The investment totals have been updated to reflect additional investment made in the days following the winner announcement. A startup developing saliva-based diagnostics to screen for oral cancers and...
Technology Targeting the BRCA1 Pseudogene (BRCA1P1) to Inhibit Cancer Progression and Increase Therapy Responses Compositions and methods to target long non-coding RNA (lncRNA) from the BRCA1 pseudogene in breast cancer cells to stimulate the body’s natural immune response, leading to increased cancer cell death…
